Search hospitals > Washington > Seattle
Swedish Medical Center
Claim this profileSeattle, Washington 98122
Global Leader in Breast Cancer
Global Leader in Lung Cancer
Conducts research for Cancer
Conducts research for Breast cancer
Conducts research for Ovarian Cancer
603 reported clinical trials
30 medical researchers
Summary
Swedish Medical Center is a medical facility located in Seattle, Washington. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Swedish Medical Center is involved with conducting 603 clinical trials across 818 conditions. There are 30 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.Area of expertise
1Breast Cancer
Global LeaderStage IV
HER2 negative
ER positive
2Lung Cancer
Global LeaderStage IV
Stage III
Stage II
Top PIs
Alison K. ConlinProvidence Portland Medical Center6 years of reported clinical research
Expert in Breast Cancer
Expert in Cancer
107 reported clinical trials
183 drugs studied
Charles W. DrescherProvidence Portland Medical Center8 years of reported clinical research
Studies Breast Cancer
Studies Non-Small Cell Lung Cancer
53 reported clinical trials
99 drugs studied
Nitya AlluriProvidence Portland Medical Center2 years of reported clinical research
Studies Uterine Cancer
Studies Endometrial Adenocarcinoma
28 reported clinical trials
79 drugs studied
Krishna C. AlluriProvidence Portland Medical Center5 years of reported clinical research
Studies Ovarian Carcinoma
Studies Ovarian Cancer
26 reported clinical trials
63 drugs studied
Clinical Trials running at Swedish Medical Center
Lung Cancer
Breast Cancer
Prostate Cancer
Breast cancer
Ovarian Cancer
Bladder Cancer
Bladder Carcinoma
Multiple Myeloma
Non-Small Cell Lung Cancer
Pancreatic Cancer
Immunotherapy + Chemotherapy
for Non-Small Cell Lung Cancer
This phase III ALCHEMIST treatment trial tests the addition of pembrolizumab to usual chemotherapy for the treatment of stage IIA, IIB, IIIA or IIIB non-small cell lung cancer that has been removed by surgery. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs, such as cisplatin, pemetrexed, carboplatin, gemcitabine hydrochloride, and paclitaxel, work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab with usual chemotherapy may help increase survival times in patients with stage IIA, IIB, IIIA or IIIB non-small cell lung cancer.
Recruiting2 awards Phase 327 criteria
Durvalumab
for Lung Cancer
This phase III trial compares durvalumab to the usual approach (patient observation) after surgery for the treatment of patients with early-stage non-small cell lung cancer. Immunotherapy with monoclonal antibodies, such as durvalumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. The usual approach for patients who are not in a study is to closely watch a patient's condition after surgery and to have regular visits with their doctor to watch for signs of the cancer coming back. Usually, patients do not receive further treatment unless the cancer returns. This study will help determine whether this different approach with durvalumab is better, the same, or worse than the usual approach of observation. Giving durvalumab may help patients live longer and prevent early-stage non-small cell lung cancer from coming back as compared to the usual approach.
Recruiting2 awards Phase 38 criteria
Chemotherapy + Immunotherapy vs. Immunotherapy
for Advanced Lung Cancer
This phase III trial compares the effect of adding chemotherapy to immunotherapy (pembrolizumab) versus immunotherapy alone in treating patients with stage IIIB-IV lung cancer. Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. Chemotherapy drugs work in different ways to stop the growth of tumor cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. Giving pembrolizumab and chemotherapy may help stabilize lung cancer.
Recruiting2 awards Phase 3
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Swedish Medical Center?
Swedish Medical Center is a medical facility located in Seattle, Washington. This center is recognized for care of Breast Cancer, Lung Cancer, Cancer, Breast cancer, Ovarian Cancer and other specialties. Swedish Medical Center is involved with conducting 603 clinical trials across 818 conditions. There are 30 research doctors associated with this hospital, such as Alison K. Conlin, Charles W. Drescher, Nitya Alluri, and Krishna C. Alluri.
Where is Swedish Medical Center located?
**Directions to Swedish Medical Center, Seattle, WA:**
- From I-5, take the James Street Exit (164A northbound, 165A southbound).
- Head east on James Street, which becomes Cherry Street.
- For the main entrance, turn left on Broadway. For the emergency department, turn left on Cherry, then right on Minor.
Who should I call to ask about financial aid or insurance network?
**Swedish Medical Center Billing and Financial Assistance Information:**
- **Billing Inquiries:**
- For general billing questions, contact Billing Customer Service at 206-320-5300 or 877-406-0438.
- For Swedish Medical Group bill inquiries, call 206-320-4476 or 888-294-9333.
- **Financial Assistance:**
- Swedish Medical Center offers financial assistance for those unable to afford care. Contact the financial assistance department via their website's contact form or email.
- **Hospital Charges Inquiries:**
- For questions about hospital charges, call 773-694-8666. Financial counselors and customer service representatives are available to assist patients with limited financial resources or coverage.
What insurance does Swedish Medical Center accept?
Swedish Medical Center, part of Swedish Hospital, accepts a broad range of insurance plans, including but not limited to Aetna, Anthem BCBS, CIGNA, and UnitedHealthcare/PERA, along with public aid, Medicare, Medicaid, and commercial insurance. Accepted plans also encompass Medicare supplemental plans (Medigap) and Medicare Part C (Medicare Advantage). For coverage verification and to ensure in-network status, contacting your insurance provider or employer is advised.
What awards or recognition has Swedish Medical Center received?
Swedish Medical Center, located in Seattle, Washington, is renowned for its outstanding healthcare services in heart and vascular, neurosciences, orthopedics, gastrointestinal, and critical care. It stands as a premier clinical trial site in the western United States, conducting over 600 research studies on conditions like coronary-artery disease, ovarian cancer, and retinopathy.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.